Stock Track | METIS TECHBIO-P Soars 5.82% on Strategic AI Drug Development Alliance with Deerfield Management

Stock Track10:24

METIS TECHBIO-P's stock price surged 5.82% intraday on Monday, driven by positive market reaction to a significant corporate development.

The sharp increase follows the company's announcement of a strategic alliance with the premier global health investment and innovation platform, Deerfield Management. The partnership is aimed at co-developing a new generation of in vivo protein therapeutics and immunotherapies, while jointly advancing the global commercialization of collaborative pipeline products.

Under the agreement, Deerfield will engage in in-depth collaboration on the global clinical development and commercial expansion initiatives related to METIS TECHBIO-P's proprietary AI-powered nano-delivery platform, NanoForge, and its core pipeline projects. This includes a leading T-cell engager project discovered by the company's in-house AiProtein platform.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1111065723?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 10:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111065723","market":"us","top_or_hot":-1,"title":"Stock Track | METIS TECHBIO-P Soars 5.82% on Strategic AI Drug Development Alliance with Deerfield Management","media":"Stock Track","content":"<p>METIS TECHBIO-P's stock price surged 5.82% intraday on Monday, driven by positive market reaction to a significant corporate development.</p><p>The sharp increase follows the company's announcement of a strategic alliance with the premier global health investment and innovation platform, Deerfield Management. The partnership is aimed at co-developing a new generation of in vivo protein therapeutics and immunotherapies, while jointly advancing the global commercialization of collaborative pipeline products.</p><p>Under the agreement, Deerfield will engage in in-depth collaboration on the global clinical development and commercial expansion initiatives related to METIS TECHBIO-P's proprietary AI-powered nano-delivery platform, NanoForge, and its core pipeline projects. This includes a leading T-cell engager project discovered by the company's in-house AiProtein platform.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | METIS TECHBIO-P Soars 5.82% on Strategic AI Drug Development Alliance with Deerfield Management</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | METIS TECHBIO-P Soars 5.82% on Strategic AI Drug Development Alliance with Deerfield Management\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-06-01 10:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>METIS TECHBIO-P's stock price surged 5.82% intraday on Monday, driven by positive market reaction to a significant corporate development.</p><p>The sharp increase follows the company's announcement of a strategic alliance with the premier global health investment and innovation platform, Deerfield Management. The partnership is aimed at co-developing a new generation of in vivo protein therapeutics and immunotherapies, while jointly advancing the global commercialization of collaborative pipeline products.</p><p>Under the agreement, Deerfield will engage in in-depth collaboration on the global clinical development and commercial expansion initiatives related to METIS TECHBIO-P's proprietary AI-powered nano-delivery platform, NanoForge, and its core pipeline projects. This includes a leading T-cell engager project discovered by the company's in-house AiProtein platform.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07666","symbol_name":"剂泰科技-P","start_time":0,"source_url":"","article_id":"1111065723","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111065723","pubTimestamp":1780280683,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"METIS TECHBIO-P's stock price surged 5.82% intraday on Monday, driven by positive market reaction to a significant corporate development.The sharp increase follows the company's announcement of a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07666":"剂泰科技-P"},"translate_title":"个股追踪|METIS TECHBIO-P飙升5.82%，与Deerfield Management达成战略AI药物开发联盟","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07666":1},"content_text":"METIS TECHBIO-P's stock price surged 5.82% intraday on Monday, driven by positive market reaction to a significant corporate development.The sharp increase follows the company's announcement of a strategic alliance with the premier global health investment and innovation platform, Deerfield Management. The partnership is aimed at co-developing a new generation of in vivo protein therapeutics and immunotherapies, while jointly advancing the global commercialization of collaborative pipeline products.Under the agreement, Deerfield will engage in in-depth collaboration on the global clinical development and commercial expansion initiatives related to METIS TECHBIO-P's proprietary AI-powered nano-delivery platform, NanoForge, and its core pipeline projects. This includes a leading T-cell engager project discovered by the company's in-house AiProtein platform.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1111065723","isCrawlerRequest":true}